STEVEN C GILMAN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for STEVEN C GILMAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of STEVEN C GILMAN. STEVEN C GILMAN is a EVP & Chief Scientific Officer in CUBIST PHARMACEUTICALS INC ($CBST) and a Senior Vice President in CUBIST PHARMACEUTICALS INC ($CBST) and a SVP, Chief Scientific Officer in CUBIST PHARMACEUTICALS INC ($CBST) and a in Vericel Corp ($ASTM) and a Director in Vericel Corp ($ASTM) and a Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and a Director in SCYNEXIS INC ($SCYX) and a Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and a CEO in CONTRAFECT Corp ($CFRX) and a in Akebia Therapeutics, Inc. ($AKBA) and a Director in Akebia Therapeutics, Inc. ($AKBA).

Address: 65 HAYDEN AVENUE LEXINGTON 02421 MA

Companies in which STEVEN C GILMAN is an Insider

Akebia Therapeutics, Inc.

Trading Symbol: AKBA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN:
Holdings: 43,431 shares
Current Value: $429,098
Latest Transaction: Jun 09 2020
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CONTRAFECT Corp

Trading Symbol: CFRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN: CEO
Holdings: 20,800 shares
Current Value: $35,360
Latest Transaction: Jul 26 2017
$CFRX Market Capitalization: $70.68M
$CFRX Previous Close: $1.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CUBIST PHARMACEUTICALS INC

Trading Symbol: CBST
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN: EVP & Chief Scientific Officer, SVP, Chief Scientific Officer, Senior Vice President
Holdings: 0 shares
Latest Transaction: Jan 21 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

KERYX BIOPHARMACEUTICALS INC

Trading Symbol: KERX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2018
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

MOMENTA PHARMACEUTICALS INC

Trading Symbol: MNTA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEVEN C GILMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 01 2020
$MNTA Market Capitalization: $1.29B
$MNTA Previous Close: $18.85

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SCYNEXIS INC

Trading Symbol: SCYX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN: Director
Holdings: 4,000 shares
Current Value: $12,600
Latest Transaction: Dec 23 2020
$SCYX Market Capitalization: $82.53M
$SCYX Previous Close: $3.15

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Vericel Corp

Trading Symbol: ASTM
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEVEN C GILMAN:
Holdings: 3,500 shares
Latest Transaction: Apr 30 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of STEVEN C GILMAN

Sentiment: All, AKBA, CFRX, CBST, KERX, MNTA, SCYX, ASTM

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 30 2021ASTMVericel CorpGILMAN STEVEN COption ExerciseA63.226,500410,9306,500
Apr 30 2021ASTMVericel CorpGILMAN STEVEN COption ExerciseA0.002,60002,600
Apr 30 2021ASTMVericel CorpGILMAN STEVEN COption ExerciseM0.001,75000
Apr 30 2021ASTMVericel CorpGILMAN STEVEN CBuyM0.001,75003,5001.8 K to 3.5 K (+100.00 %)
Dec 23 2020SCYXSCYNEXIS INCGILMAN STEVEN CDirectorOption ExerciseA8.252,00016,5002,000
Dec 23 2020SCYXSCYNEXIS INCGILMAN STEVEN CDirectorOption ExerciseA7.332,00014,6602,000
Dec 23 2020SCYXSCYNEXIS INCGILMAN STEVEN CDirectorBuyP6.254,00025,0004,0000 to 4 K

View all STEVEN C GILMAN insider transactions.